Skip to main content
. Author manuscript; available in PMC: 2021 Dec 30.
Published in final edited form as: J Proteome Res. 2016 Jul 8;15(8):2455–2465. doi: 10.1021/acs.jproteome.5b01129

Table 1.

Clinical Characteristics of Ovarian Serous Carcinoma Patients under Study

characteristic summary
number of patients 130
age (mean ± SD) 60.8 ± 11.6 years
Histology Type
 serous 130 (100%)
Tumor Stage
 I 2 (1.54%)
 II 8 (6.15%)
 III 96 (73.85%)
 IV 24 (18.46%)
Grade
 G1 0 (0%)
 G2 21 (16.15%)
 G3 107 (82.31%)
 GX 2 (1.54%)
overall platinum free interval (mean ± SD) 7.99 ± 14.21 months
Platinum Status
 platinum sensitive 95 (73.08%)
  PFI in platinum-sensitive patients 3.05 ± 1.83 months
 platinum resistant 35 (26.92%)
  PFI in platinum-resistant patients 19.39 ± 18.64 months
Vital Status
 alive 57 (43.85%)
 dead 73 (56.15%)